GLP-1 receptors in the hypothalamus region control appetite, satiety, food reward
So more than one in 10 American adults is currently using a GLP-1 drug for weight loss, and more than one in seven have used it at some point in the past, the Gallup Index revealed
La carnitina un bruciagrassi
Now anyone who is obese as defined by body mass index (BMI) or who is overweight per BMI and has at least one weight-related health condition is eligible for a GLP-1 prescription
The most commonly reported adverse effects are gastrointestinal in nature, including nausea, vomiting, diarrhoea, and constipation, particularly during the initial dose escalation period
This is also when you typically increase the dose according to your titration schedule